March 12 (Reuters) - Kura Oncology Inc:
* KURA ONCOLOGY INC - ON MARCH 12, 2018, CO ENTERED INTO AN AMENDED AND RESTATED SALES AGREEMENT WITH COWEN AND COMPANY, LLC - SEC FILING
* KURA ONCOLOGY-INCREASED MAXIMUM AGGREGATE OFFERING PRICE OF SHARES OF CO'S COMMON STOCK, THAT IS CO MAY OFFER AND SELL FROM $100.0 MILLION TO $160.0 MILLION Source text (bit.ly/2HrCHZZ) Further company coverage: (Reuters.Brief@thomsonreuters.com)